KDIGO

Why Can’t We Flozinate? Reflections on Our Inability to Optimally Prescribe SGLT2 Inhibitors to the Patients That Need Them Most

September 20, 2023 // 0 Comments

Dr. James Torain is a second-year nephrology fellow at Duke University Hospital. He currently has an interest in implementation of home dialysis modalities. Health [...]

Does Acetaminophen Prevent AKI in Patients Undergoing Cardiac Surgery?

June 28, 2023 // 0 Comments

Dilushi Wijayaratne @Dilushiwijay Dilushi Wijayaratne graduated from the Faculty of Medicine Colombo in 2010, completed her MD (Medicine) in 2016, and was board-certified as [...]

Sick Day Medication Guidance: How to Minimize The Harm of Double-Edged Swords?

May 17, 2023 // 0 Comments

Mengyao Tang @tammyyaotang Dr. Mengyao Tang is a research fellow at Massachusetts General Hospital, as well as a board-certified nephrologist who has a particular interest [...]

#NephMadness 2023: It’s Always Rosy in the World of Complement

March 16, 2023 // 0 Comments

Submit your picks! | NephMadness 2023 | #NephMadness | #TMAregion John Sperati @JohnSperati Dr. John Sperati is an Associate Professor of Medicine and an adult nephrologist [...]

Atherosclerotic Renovascular Disease: A Panel Discussion

June 8, 2022 // 0 Comments

In a recent Special Report published in AJKD, Caitlin W. Hicks and colleagues discuss the epidemiology, diagnosis, and treatment of atherosclerotic renovascular disease [...]

Highlights from the April 2022 Issue

April 1, 2022 // 0 Comments

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]

Will You Take the Blue or Red Pill?

June 30, 2021 // 1 Comment

Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]

Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO Guideline

February 22, 2019 // 0 Comments

Over the last few years, the management of hepatitis C has been revolutionized by the advent of direct antiviral agents (DAA). This has arguably been one of the most [...]

#KidneyWk 2017: KDIGO Guideline and Conference Updates

November 28, 2017 // 0 Comments

As KDIGO Social Media Ambassador, I always make it a point to attend the KDIGO Guideline and Conference Updates at Kidney Week. It always provides a nice compendium of [...]

KDIGO Guidelines on Living Kidney Donors: A Call for A Paradigm Shift

October 27, 2017 // 0 Comments

The much-anticipated KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors was recently published. It is available in two versions: a 10-page [...]